Dr. Gerald Diaz @GeraldMD
23.1M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
15 results
management infections prevention idsa comparison methadone mycobacterium opioid usedisorder 2016 aace addiction aviumcomplex candida candidiasis capsulatum chagas cmv cytomegalovirus decisionaid
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity Mechanism of Action,
Table of Weight-Loss ... Medications approved ... the long-term treatment ... Mechanism of Action, Dose ... WeightLoss #AACE #2016 #Pharmacology
Opioid Use Disorder Medications - Pharmacokinetics Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
in which higher doses ... margin of safety in pharmacology ... the sublingual tablet ... Pharmacokinetics #Comparison #Table ... #Pharmacology #
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table Some patients may decline buprenorphine
- Comparison Table ... interested in medication ... assisted treatment ... formulation, the dose ... Hospital Opioid Use Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
be considered (doses ... PO in 2 divided doses ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
Achieve a total dose ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
Encephalitis in HIV-AIDS Indications ... IDSA #Prevention #Treatment ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
increase daily dose ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS Early Stage (Primary, Secondary,
million U IM for 1 dose ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
., concomitant medications ... injection) for 1–4 doses ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
empty